<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04684992</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-CD-046</org_study_id>
    <nct_id>NCT04684992</nct_id>
  </id_info>
  <brief_title>GEBT Telehealth Administration Usability Study</brief_title>
  <official_title>Telehealth Administration of 13C-Spirulina Gastric Emptying Breath Test (13C-GEBT) Usability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairn Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairn Diagnostics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the usability of a telehealth platform for the&#xD;
      administration of GEBT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is intended to demonstrate that the 13C-Spirulina Gastric Emptying Breath Test&#xD;
      (GEBT) can be successfully administered via a telehealth platform. Telehealth administration&#xD;
      of GEBT is where a trained Cairn employee uses a video link to remotely supervise the&#xD;
      completion of the test request form, collection of breath samples, cooking and consumption of&#xD;
      the test meal and return of breath samples by the patient to Cairn.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 11, 2020</start_date>
  <completion_date type="Actual">March 10, 2021</completion_date>
  <primary_completion_date type="Actual">March 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions</measure>
    <time_frame>1 day</time_frame>
    <description>Ability to prepare GEBT will be assessed by the telehealth administrator's observation of the patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Ability to prepare GEBT will be assessed by a patient questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions</measure>
    <time_frame>2-4 days</time_frame>
    <description>Ability to complete the GEBT test request form will be assessed by Cairn accessioning personnel upon receipt of returned breath samples.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Ability to complete the GEBT test request form will be assessed by a patient questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Ability to collect GEBT breath samples will be assessed by examination of GEBT results for participants (ensuring adequate CO2 in each sample/delta values follow expected pattern if collected in correct order).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability to Successfully Ship Kits/Breath Samples to/From Home</measure>
    <time_frame>Up to 3 weeks</time_frame>
    <description>Ability to ship GEBT kits/breath samples to/from home will be assessed by surveying patients regarding shipping and by recording the dates that kits were shipped and received</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability of a Telehealth Platform to Function Correctly</measure>
    <time_frame>1 day</time_frame>
    <description>Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a telehealth administrator questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability of a Telehealth Platform to Function Correctly</measure>
    <time_frame>Up to 3 weeks</time_frame>
    <description>Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a patient questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of Telehealth Administration of 13C-Spirulina GEBT Versus Administration in a Clinician's Facility</measure>
    <time_frame>Up to 3 weeks</time_frame>
    <description>Any adverse events reported will be reviewed by Cairn's medical director to assess that there is no more than expected frequency of adverse events during administration of GEBT by a telehealth professional than would be expected during administration of GEBT in a clinician's facility. This will be performed by comparing the current rate of events in a physician's office versus under the supervision of a telehealth professional as identified through the risk analyses performed for GEBT administration.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Gastroparesis</condition>
  <arm_group>
    <arm_group_label>GEBT Telehealth Administration Usability</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Establish the usability of a telehealth platform for the administration of GEBT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GEBT Telehealth Administration Usability</intervention_name>
    <description>Establish the usability of a telehealth platform for the administration of GEBT</description>
    <arm_group_label>GEBT Telehealth Administration Usability</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females, greater than or equal to 18 years of age at the time of signing the&#xD;
             consent form, from healthy and intended use population (i.e. symptomatic for&#xD;
             gastroparesis). Women of childbearing potential must not be pregnant at the time of&#xD;
             GEBT administration.&#xD;
&#xD;
          -  Ability to eat test meal and provide breath samples&#xD;
&#xD;
          -  Access to a microwave oven at home&#xD;
&#xD;
          -  Internet connection and telehealth accessible device (smart phone/tablet/computer with&#xD;
             visual and voice capability) at home&#xD;
&#xD;
          -  Environment to sit comfortably and quietly at home&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History or physical exam suggestive of systemic disease such as pathophysiologic&#xD;
             disorders such as renal failure, chronic heart disease, chronic respiratory disease,&#xD;
             liver disease, or malabsorption syndrome&#xD;
&#xD;
          -  History of abdominal surgery except appendectomy&#xD;
&#xD;
          -  Females on hormone replacement therapy other than birth control medications&#xD;
&#xD;
          -  Receipt of any investigational drug within 4 weeks of the study&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Intolerance or allergy to any component of GEBT meal&#xD;
&#xD;
          -  History of neurological or psychiatric disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex Ryder, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairn Diagnostics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairn Diagnostics</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <results_first_submitted>July 29, 2021</results_first_submitted>
  <results_first_submitted_qc>July 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 24, 2021</results_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastroenterology</keyword>
  <keyword>Gastric emptying breath test</keyword>
  <keyword>Telehealth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 14, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT04684992/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>GEBT Telehealth Administration Usability</title>
          <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GEBT Telehealth Administration Usability</title>
          <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions</title>
        <description>Ability to prepare GEBT will be assessed by the telehealth administrator's observation of the patient.</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions</title>
          <description>Ability to prepare GEBT will be assessed by the telehealth administrator's observation of the patient.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Transfer meal to cooking cup without spilling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Remove oxygen absorber</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Added correct amount of water</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Egg meal cooked for correct length of time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Egg flipped middle of cooking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Egg appeared adequately cooked</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions</title>
        <description>Ability to prepare GEBT will be assessed by a patient questionnaire.</description>
        <time_frame>up to 1 week</time_frame>
        <population>Study participants assessed on a patient questionnaire whether the meal preparation instructions were clear and easy to follow.</population>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions</title>
          <description>Ability to prepare GEBT will be assessed by a patient questionnaire.</description>
          <population>Study participants assessed on a patient questionnaire whether the meal preparation instructions were clear and easy to follow.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions</title>
        <description>Ability to complete the GEBT test request form will be assessed by Cairn accessioning personnel upon receipt of returned breath samples.</description>
        <time_frame>2-4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions</title>
          <description>Ability to complete the GEBT test request form will be assessed by Cairn accessioning personnel upon receipt of returned breath samples.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Test Request Form returned with samples</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient Information Entered Correctly</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-meal sample times recorded</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Meal start/end times recorded correctly</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-meal sample times recorded</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions</title>
        <description>Ability to complete the GEBT test request form will be assessed by a patient questionnaire.</description>
        <time_frame>up to 1 week</time_frame>
        <population>Participants assessed easy of completing the GEBT test request form.</population>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions</title>
          <description>Ability to complete the GEBT test request form will be assessed by a patient questionnaire.</description>
          <population>Participants assessed easy of completing the GEBT test request form.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional</title>
        <description>Ability to collect GEBT breath samples will be assessed by examination of GEBT results for participants (ensuring adequate CO2 in each sample/delta values follow expected pattern if collected in correct order).</description>
        <time_frame>up to 1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional</title>
          <description>Ability to collect GEBT breath samples will be assessed by examination of GEBT results for participants (ensuring adequate CO2 in each sample/delta values follow expected pattern if collected in correct order).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Telehealth administrator observed condensate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post meal samples collected within 5 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clinical lab personnel observed condensate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adequate %CO2 (&gt;1%)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Samples follow excretion curve shape</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breath samples easy to collect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ability to Successfully Ship Kits/Breath Samples to/From Home</title>
        <description>Ability to ship GEBT kits/breath samples to/from home will be assessed by surveying patients regarding shipping and by recording the dates that kits were shipped and received</description>
        <time_frame>Up to 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Ability to Successfully Ship Kits/Breath Samples to/From Home</title>
          <description>Ability to ship GEBT kits/breath samples to/from home will be assessed by surveying patients regarding shipping and by recording the dates that kits were shipped and received</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Kit arrived before test administration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breath samples received within 28-days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ability of a Telehealth Platform to Function Correctly</title>
        <description>Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a telehealth administrator questionnaire</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Ability of a Telehealth Platform to Function Correctly</title>
          <description>Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a telehealth administrator questionnaire</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No platform issues?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No lost connection?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No text reminder issues?</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ability of a Telehealth Platform to Function Correctly</title>
        <description>Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a patient questionnaire</description>
        <time_frame>Up to 3 weeks</time_frame>
        <population>Participants assessed reliability and ease of use of telehealth platform.</population>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Ability of a Telehealth Platform to Function Correctly</title>
          <description>Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a patient questionnaire</description>
          <population>Participants assessed reliability and ease of use of telehealth platform.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Safety of Telehealth Administration of 13C-Spirulina GEBT Versus Administration in a Clinician's Facility</title>
        <description>Any adverse events reported will be reviewed by Cairn's medical director to assess that there is no more than expected frequency of adverse events during administration of GEBT by a telehealth professional than would be expected during administration of GEBT in a clinician's facility. This will be performed by comparing the current rate of events in a physician's office versus under the supervision of a telehealth professional as identified through the risk analyses performed for GEBT administration.</description>
        <time_frame>Up to 3 weeks</time_frame>
        <population>There were no adverse events associated with telehealth administration via the telehealth procedure (e.g., burns during microwave cooking or injuries from breath collection apparatus).</population>
        <group_list>
          <group group_id="O1">
            <title>GEBT Telehealth Administration Usability</title>
            <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
          </group>
        </group_list>
        <measure>
          <title>Safety of Telehealth Administration of 13C-Spirulina GEBT Versus Administration in a Clinician's Facility</title>
          <description>Any adverse events reported will be reviewed by Cairn's medical director to assess that there is no more than expected frequency of adverse events during administration of GEBT by a telehealth professional than would be expected during administration of GEBT in a clinician's facility. This will be performed by comparing the current rate of events in a physician's office versus under the supervision of a telehealth professional as identified through the risk analyses performed for GEBT administration.</description>
          <population>There were no adverse events associated with telehealth administration via the telehealth procedure (e.g., burns during microwave cooking or injuries from breath collection apparatus).</population>
          <units>AEs associated with telehealth</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>GEBT Telehealth Administration Usability</title>
          <description>Establish the usability of a telehealth platform for the administration of GEBT&#xD;
GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Excessive burping and nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Severe bloating and excessive gas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Vomiting and dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chief Scientist and Compliance Officer</name_or_title>
      <organization>Cairn Diagnostics</organization>
      <phone>615-376-5464</phone>
      <email>cwilliams@cairndx.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

